News of the WeekCancer Research

Leukemia Protein Spurs Gene Silencing

Science  08 Feb 2002:
Vol. 295, Issue 5557, pp. 943-945
DOI: 10.1126/science.295.5557.943b

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution

This article has a correction. Please see:


On page 1079, researchers report that a mutant oncogenic protein involved in development of a blood cancer known as acute promyelocytic leukemia (APL) recruits enzymes that attach methyl groups to DNA, in this case to a possible tumor suppressor gene called RARb2. The addition of these methyl groups silences the gene, and that in turn contributes to the malignant transformation of the leukemia cells, the researchers report. This finding could lead to better APL therapies aimed at blocking methylation of RARb2 and other targets of the oncogenic protein.